Method for the prevention of ocular hypertension, treatment of g

Details Method for the prevention of ocular hypertension, treatment of g Method for the prevention of ocular hypertension, treatment of g

1984-10-22

1986-10-14

Roberts, Elbert L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514453, A61K 3156, A61K 3135

Patent

active

046172998

ABSTRACT:
A novel pharmacologic therapy for treatment of idiopathic primary open angle glaucoma, drug-induced glaucoma and elevated intraocular pressure is disclosed. The pharmacologic therapy consists of a novel composition comprised of a selected anabolic androgenic compound and a physiologically tolerable carrier. In accordance with a method aspect of this invention, the pharmacologic substance is administered to the eye of a warm blooded animal in such a manner as to maintain physiologic or normal intraocular pressure, or to return elevated intraocular pressure to normal levels. The method aspect of this invention may also be employed to prevent drug induced elevated intraocular pressure.

REFERENCES:
Lamble et al; Exp. Eye Res., vol. 26 (1978) pp. 599-610.
"Steroids" by Fieser et al., p. 519.
Modern Drug. Encyclopedia (1975) pp. 577, 578, 579 and 780.

Affiliated with

Also associated with

Rating

Method for the prevention of ocular hypertension, treatment of g does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the prevention of ocular hypertension, treatment of g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prevention of ocular hypertension, treatment of g will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1340460